Minahasa Membangun Hebat Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Minahasa Membangun Hebat Tbk. trades at Rp272 (market cap 283.08B), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B). The key difference: Minahasa Membangun Hebat Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| HBAT | OBAT | |
|---|---|---|
Market Cap | 283.08B | 167.37B |
Trailing returns across standard periods
Latest headlines on both assets
PT Minahasa Membangun Hebat Tbk was established based on Notarial Deed No. 44 datedJanuary 31, 2020 of Dian Fitriana, S.H., M.Kn., a public notary in Bekasi.
Read more on HBAT →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →